CVE-2011-2309 in Industry Applications
Summary
by MITRE
Unspecified vulnerability in the Health Sciences - Oracle Clinical, Remote Data Capture component in Oracle Industry Applications 4.6 and 4.6.2 allows remote attackers to affect integrity, related to RDC Help.
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Analysis
by VulDB Data Team • 05/08/2017
The vulnerability identified as CVE-2011-2309 resides within Oracle Clinical's Remote Data Capture component, specifically within the Health Sciences industry applications version 4.6 and 4.6.2. This flaw represents a security weakness that enables remote attackers to compromise data integrity within the system. The vulnerability is classified as unspecified, indicating that the exact technical mechanism remains undisclosed, though its impact on data integrity is clearly defined. The affected component is part of Oracle's broader Industry Applications suite, which serves healthcare organizations in managing clinical trial data and research information. The Remote Data Capture functionality allows users to collect and transmit clinical data from remote locations, making it a critical component for healthcare data management operations. This system typically handles sensitive patient information and clinical trial data, making any integrity compromise particularly concerning for healthcare organizations and regulatory compliance.
The technical nature of this vulnerability suggests a weakness in how the RDC Help functionality processes or validates data inputs, potentially allowing attackers to manipulate or corrupt data within the system. While the specific implementation details are not provided in the CVE description, the classification indicates that the flaw exists in the data handling mechanisms of the help system component. This could involve issues such as insufficient input validation, improper data sanitization, or inadequate access controls within the help subsystem. The unspecified nature of the vulnerability means that attackers may exploit various potential weaknesses in the data integrity protection mechanisms, including injection attacks, data manipulation, or unauthorized modification of help content that could subsequently affect the broader system functionality. The vulnerability's impact on integrity suggests that malicious actors could alter data in ways that compromise the accuracy and reliability of clinical research information.
The operational impact of CVE-2011-2309 extends significantly beyond simple data corruption, particularly within healthcare environments where data integrity is paramount for regulatory compliance and patient safety. Healthcare organizations relying on Oracle Clinical systems for clinical trial management may face serious consequences including compromised research data, regulatory violations under HIPAA and FDA regulations, and potential safety risks from altered clinical information. The remote nature of the attack vector means that threat actors do not require physical access to the system, enabling attacks from any location with network connectivity. This vulnerability particularly affects clinical research organizations that depend on accurate data capture and reporting for regulatory submissions and study outcomes. Organizations may experience audit failures, regulatory penalties, and loss of credibility if data integrity is compromised. The vulnerability's presence in multiple versions (4.6 and 4.6.2) suggests it was a persistent issue requiring attention across the product lifecycle, indicating potential design flaws or inadequate security testing during development phases.
Organizations should implement comprehensive mitigation strategies addressing this vulnerability through immediate patch management and security configuration updates. Oracle typically releases security patches and updates for such vulnerabilities, which should be applied promptly to remediate the issue. Network segmentation and access controls should be enhanced to limit exposure of the affected component, particularly restricting access to the RDC Help functionality. Regular security assessments and vulnerability scanning should be conducted to identify potential exploitation vectors and monitor for similar issues within the broader Oracle application environment. The vulnerability aligns with CWE categories related to data integrity protection and input validation, and may be categorized under ATT&CK techniques involving data manipulation and privilege escalation. Organizations should also consider implementing data integrity monitoring solutions and audit logging to detect potential exploitation attempts. Due to the unspecified nature of the vulnerability, defensive measures should include comprehensive network monitoring, intrusion detection systems, and application-level security controls to prevent unauthorized data modification. Regular staff training on security awareness and incident response procedures is essential to maintain organizational resilience against such threats.